PhotoBarr Avrupa Birliği - İspanyolca - EMA (European Medicines Agency)

photobarr

pinnacle biologics b.v.  - de sodio porfimer - el esófago de barrett - agentes antineoplásicos - la terapia fotodinámica (tfd) con photobarr está indicado para: la ablación de la displasia de alto grado (dag) en pacientes con el esófago de barrett (bo).

ZOLADEX 3,6mg IMPLANTE Peru - İspanyolca - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

zoladex 3,6mg implante

astrazeneca peru s.a. - acetato de goserelina; - implante - por pastilla - goserelina

SINGULAIR 4 mg COMPRIMIDO MASTICABLE Peru - İspanyolca - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

singulair 4 mg comprimido masticable

organon biosciences peru s.r.l. - droguerÍa - comprimido masticable - por comprimido - - montelukast

Plerixafor Accord Avrupa Birliği - İspanyolca - EMA (European Medicines Agency)

plerixafor accord

accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - inmunoestimulantes, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.